Compare Axogen Inc (AXGN) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Exxon Mobil Corporation — how do they compare? Axogen Inc trades at $49.58 (market cap $2.67B), while Exxon Mobil Corporation trades at $158.46 (market cap $656.88B). The key difference: Exxon Mobil Corporation is far larger — about 246× Axogen Inc's market cap, and Exxon Mobil Corporation pays a 2.58% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | XOM | |
|---|---|---|
Market Cap | $2.67B | $656.88B |
Sector | Technology | Energy |
52-Week High | $49.67 | $171.52 |
52-Week Low | $14.76 | $106.49 |
Enterprise Value | $2.58B | $688.66B |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $49.67, up 3.01% with strong technical momentum. The stock shows bullish moving average signals despite recent earnings misses. Q2 2026 revenue grew 23.1% to $69.7M with raised full-year guidance to $279M, though net margins remain negative at -13.36%. Analyst consensus is strongly bullish with 16 buy ratings and $54.33 price target.
Growth prospects appear strong with expanding nerve care platform and reimbursement wins, but profitability challenges and high valuation multiples present risks. The stock trades near resistance at $50 with RSI indicating overbought conditions, suggesting potential near-term consolidation before further upside.
ExxonMobil (XOM) trades at $159.8, up 0.01% on the day, with a bullish technical signal and strong cash flow from operations of $52.0 billion in 2025. Recent earnings show mixed results, with a Q2 2026 miss but beats in prior quarters. The company maintains a solid balance sheet with a debt-to-asset ratio of 8.42% and continues shareholder returns via dividends, including the recent $1.03 per share payout.
XOM offers stable income with a 12.55% ROE and analyst consensus price target of $163.71, suggesting modest upside. Risks include declining revenue trends and oil price volatility, but low breakeven costs in the Permian Basin provide resilience. Institutional sentiment is cautiously optimistic, with 38.89% of analysts rating it a buy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
